Literature DB >> 12112075

Relapsed and late-onset Nipah encephalitis.

Chong Tin Tan1, Khean Jin Goh, Kum Thong Wong, Sazilah Ahmad Sarji, Kaw Bing Chua, Nee Kong Chew, Paramsothy Murugasu, Yet Lin Loh, Heng Thay Chong, Kay Sin Tan, Tarmizi Thayaparan, Shalini Kumar, Mohd Rani Jusoh.   

Abstract

An outbreak of infection with the Nipah virus, a novel paramyxovirus, occurred among pig farmers between September 1998 and June 1999 in Malaysia, involving 265 patients with 105 fatalities. This is a follow-up study 24 months after the outbreak. Twelve survivors (7.5%) of acute encephalitis had recurrent neurological disease (relapsed encephalitis). Of those who initially had acute nonencephalitic or asymptomatic infection, 10 patients (3.4%) had late-onset encephalitis. The mean interval between the first neurological episode and the time of initial infection was 8.4 months. Three patients had a second neurological episode. The onset of the relapsed or late-onset encephalitis was usually acute. Common clinical features were fever, headache, seizures, and focal neurological signs. Four of the 22 relapsed and late-onset encephalitis patients (18%) died. Magnetic resonance imaging typically showed patchy areas of confluent cortical lesions. Serial single-photon emission computed tomography showed the evolution of focal hyperperfusion to hypoperfusion in the corresponding areas. Necropsy of 2 patients showed changes of focal encephalitis with positive immunolocalization for Nipah virus antigens but no evidence of perivenous demyelination. We concluded that a unique relapsing and remitting encephalitis or late-onset encephalitis may result as a complication of persistent Nipah virus infection in the central nervous system.

Entities:  

Mesh:

Year:  2002        PMID: 12112075     DOI: 10.1002/ana.10212

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  79 in total

Review 1.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

2.  Nipah virus: vaccination and passive protection studies in a hamster model.

Authors:  V Guillaume; H Contamin; P Loth; M-C Georges-Courbot; A Lefeuvre; P Marianneau; K B Chua; S K Lam; R Buckland; V Deubel; T F Wild
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

4.  Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.

Authors:  Alexander Freiberg; Lhia Krista Dolores; Sven Enterlein; Ramon Flick
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

Review 5.  [Acute viral and emerging viral CNS infections].

Authors:  S Menon; T Lenhard; U Meyding-Lamadé
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 6.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

Review 7.  Ecological dynamics of emerging bat virus spillover.

Authors:  Raina K Plowright; Peggy Eby; Peter J Hudson; Ina L Smith; David Westcott; Wayne L Bryden; Deborah Middleton; Peter A Reid; Rosemary A McFarlane; Gerardo Martin; Gary M Tabor; Lee F Skerratt; Dale L Anderson; Gary Crameri; David Quammen; David Jordan; Paul Freeman; Lin-Fa Wang; Jonathan H Epstein; Glenn A Marsh; Nina Y Kung; Hamish McCallum
Journal:  Proc Biol Sci       Date:  2015-01-07       Impact factor: 5.349

Review 8.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

9.  Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.

Authors:  James E Strong; Gary Wong; Shane E Jones; Allen Grolla; Steven Theriault; Gary P Kobinger; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

10.  Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.

Authors:  Alexander N Freiberg; Melissa N Worthy; Benhur Lee; Michael R Holbrook
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.